Mild IVF using GnRH agonist long protocol is possible: Comparing stimulations with 100 IU vs. 150 IU recombinant FSH as starting dose

Journal of Assisted Reproduction and Genetics

Volumn 26, Issue 2-3, 2009, Pages 75-82

  Fernández Shaw, Sylvia ^a   Pérez Esturo, Nuria ^a   Cercas Duque, Rosa ^a   Pons Mallol, Isabel ^a  

^a URH García Del Real ^*  (Spain)

Author keywords

GnRH agonist; IVF; Long protocol; Mild ovarian stimulation; RFSH

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; HCG LEPORI; NAFARELIN ACETATE; PROGEFFIK; PROGESTERONE; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COST BENEFIT ANALYSIS; DRUG DOSE COMPARISON; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OOCYTE MATURATION; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TWINS;

EID: 62449138037     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-008-9289-z     Document Type: Article

References (30)

1. G Nargund R Frydman 2007 Towards a more physiological approach to IVF Reprod Biomed Online 14 550 2
2. H Hassan-Ali A Hisham-Saleh D El-Gezeiry I Baghdady I Ismaeli J Mandelbaum 1998 Perivitelline space granularity: a sign of human menopausal gonadotrophin overdose in intracytoplasmic sperm injection Hum Reprod 13 3425 30
3. H Balakier D Bouman A Sojecki C Librach JA Squire 2002 Morphological and cytogenetic analysis of human giant oocytes and giant embryos Hum Reprod 17 2394 401
4. MC Magli AP Ferraretti A Crippa M Lappi E Feliciani L Gianaroli 2006 First meiosis errors in immature oocytes generated by stimulated cycles Fertil Steril 86 629 35
5. T Hassold P Hunt 2001 To err (meiotically) is human: the genesis of human aneuploidy Nat Rev Genet 2 280 91
6. S Munné C Magil A Adler G Wright K de Boer D Mortimer 1997 Treatment related chromosome abnormalities in human embryos Hum Reprod 12 780 4
7. EB Baart E Martini MJ Eijkemans D Van Optal NGM Beckers A Verhoeff 2007 Milder ovarian stimulation for in-vitro fertilisation reduces aneuploidy in the human preimplantation embryo: a randomised controlled trial Hum Reprod 22 980 8
8. RJ Paulson MV Sauer RA Lobo 1990 Embryo implantation after human in vitro fertilization: importance of endometrial receptivity Fertil Steril 53 870 4
9. GS Basir 2001 OWS, Ng EH and Ho PC: Morphometric analysis of the peri-implantation endometrium in patients having excessively high-oestradiol concentratrions after ovarian stimulation Hum Reprod 16 435 40
10. C Simón F Dominguez D Valbuena A Pellicer 2003 The role of estrogen in uterine receptivity and blastocyst implantation Trends Endocrinol Metab 14 197 9
11. P Devroey C Bourgain NS Macklon BCJM Fauser 2004 Reproductive biology and IVF: ovarian stimulation and endometrial receptivity Trends Endocrinol Metab 15 84 90
12. BA Kolb RJ Paulson 1997 The luteal phase of cycles utilising controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation Am J Obs Gyn 176 1262 9
13. A Tavanitou C Albano J Smitz P Devroey 2002 Impact of ovarian stimulation on corpus luteum function and embryonic implantation Reprod Immunol 55 123 30
14. JA Martínez-Conejero C Simón A Pellicer JA Horcajadas 2007 Is ovarian stimulation detrimental to the endometrium? Reprod Biomed Online 15 45 50
15. JS Abramowicz DF Archer 1990 Uterine endometrial peristalsis-a transvaginal ultrasound study Fertil Steril 54 451 4
16. P Lesny SR Killick RL Tetlow J Robinson SD Maguiness 1998 Uterine junctional zone contractions during assisted reproduction cycles Hum Reprod Update 4 440 5
17. S Killick 2007 Ultrasound and the receptivity of the endometrium Reprod Biomed Online 15 63 7
18. S Polinder EMEW Heijnen NS Macklon JDF Habbema BJCM Fauser MJC Eijkemans 2008 Cost effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint Hum Reprod 23 316 23
19. G Nargund BCJM Fauser NS Macklon W Ombelet K Nygren R Frydman 2007 The ISMAAR proposal on terminology for ovarian stimulation for IVF Hum Reprod 11 2801 4
20. P Devroey H Tournaye A Van Steirteghem P Hendrix HJ Out 1998 The use of a 100 IU starting dose of recombinant FSH (Puregon) in in-vitro fertilization Hum Reprod 13 565 6
21. ®) in Korean women undergoing in vitro fertilization and embryo transfer J Obstet Gynaecol Res 29 174 9
22. HJ Out S Lindenberg AL Mikkelsen T Eldar-Geva DL Healy A Leader 1999 A prospective randomised doubled-blind clinical trial to study efficacy of a fixed dose of recombinant follicle stimulating hormone (Puregon) in woman undergoing ovarian stimulation Hum Reprod 14 622 7
23. S Fernández-Shaw C Grande E Gallego L Rodríguez M Mayoral G Capmany 2000 Procrin en protocolo largo de FIV. Comparación entre dos dosis Rev Ib Fertil 17 109 10
24. L Stadtmauer EC Ditkoff D Session A Kelly 1994 High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer Fertil Steril 61 1058 64
25. Z Ben Rafael CA Benadiva M Ausmanas B Barber L Blasco GL Flickinger 1987 Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program Fertil Steril 48 964 8
26. M Wikland C Bergh K Borg T Hillensjö CM Howles A Knutsson 2001 A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI Hum Reprod 16 1676 81
27. HJ Out A Rutherford R Fleming CCK Tay G Trew W Ledger 2004 A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction Hum Reprod 19 90 5
28. HJ Out DD Bratt B Linsten T Gurgan O Bukulmez O Gökmen 2000 Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation Hum Reprod 15 29 35
29. E Heijnen JC Marinus C De Klerck S Polinder NGM Beckers ER Klinkert 2007 A mild treatment for in-vitro fertilisation: a Randomised non-inferiority trial Lancet 369 743 9
30. RG Edwards R Lobo P Bouchard 1996 Time to revolutionize ovarian stimulation Hum Reprod 11 917 9